Your local 340B hospitals and federally qualified health centers aren’t the villains in this story. They are the safety net.

A recent report from the Congressional Budget Office found no evidence that savings from the 340B program are passed on to ...

Reforming the federal 340B Drug Pricing Program is a fast and efficient way to reduce drug costs and protect patients. These days, some 340B hospitals are taking advantage of low-income and uninsured ...

If drugmakers have their way, the federal government likely ends up spending $100 billion of taxpayer funds to bail out rural hospitals.

AHA writes to express our strong support for this vital program that allows eligible hospitals to maintain, improve and expand access to essential services and medications for the patients and ...

FAH rebuts Senate hearing claims, clarifying taxpaying hospitals do not benefit from the 340B drug pricing program discounts.

Bausch Health has exited Medicaid and a federal government drug discount scheme known as 340B, a step that suggests more ...

The American Society of Health-System Pharmacists is urging lawmakers to protect the 340B Drug Pricing Program, warning that changes to the discount model could destabilize safety-net hospitals. In an ...

For the 5,000 people in Illinois living with sickle cell disease, access to affordable medical care and life-saving ...

Ryan Long, the co-author of a recent USC Schaeffer Center white paper on the 340B Drug Pricing Program, argues that meaningful reform requires shifting to a direct subsidy model based on need. The ...

For many Ohio businesses, the word “expansion” typically signals growth, opportunity and new jobs. However, over time, the program has grown far beyond its original scope. Large hospital systems, ...